Discovery Of 2-Alkyl-1-Arylsulfonylprolinamides As 11 Beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitors

Jianxin Yu,Haiyan Liu,Guangxin Xia,Lin Liu,Zhenmin Xu,Qian Chen,Chen Ma,Xing Sun,Jiajun Xu,Hua Li,Ping Li,Yufang Shi,Bing Xiong,Xuejun Liu,Jingkang Shen
DOI: https://doi.org/10.1021/ml300144n
2012-01-01
ACS Medicinal Chemistry Letters
Abstract:On the basis of scaffold hopping, a novel series of 2-alkyl-1-arylsulfonylprolinamides was discovered as 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD-1) inhibitors. A representative compound 4ek, obtained through SAR and structure optimization studies, demonstrates excellent in vitro potency against 11 beta-HSD-1 and dose-dependent in vivo inhibition of 11 beta-HSD-1 in a prednisone/prednisolone transformation biomarker study in mice.
What problem does this paper attempt to address?